# TJM Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tjm-labs

- Industry: Healthcare IT
- Headquarters: Delaware, US
- Website: www.tjmlabs.com/
- Total disclosed funding: $75M
- Latest round: Series B (Jul 2, 2026)
- Investors on record: 3

## About

Based in the US, TJM Labs, LLC specializes in delivering innovative AI-driven automation solutions tailored for pharmacies, enhancing operational efficiency and reducing manual labor in pharmacy workflows.TJM Labs, LLC develops automation technology specifically for the pharmacy sector, focusing on improving operational efficiency. Founded in 2024 in Delaware, US, the company has completed 3 deals. The latest funding round, Series A, raised USD 15.00 mn, which is the total amount raised to date. The company does not have known subsidiaries or parent companies, and there is no available information regarding the founder.TJM Labs specializes in developing AI-driven automation solutions tailored for the pharmacy sector, focusing on enhancing operational efficiency. Their primary offerings include advanced AI agents designed for prescription intake, data entry, refill management, and patient communication, aimed at reducing manual labor and errors in pharmacy workflows. These automation tools are built specifically for pharmacy management systems (PMS), ensuring seamless integration without the need for APIs or system replacements. The client base includes over 450 pharmacies across North America, encompassing independent pharmacies, specialty and compounding pharmacies, and long-term care facilities, with products serving both U.S. and Canadian markets.TJM Labs generates revenue through B2B partnerships with pharmacies that utilize their automation solutions. Their revenue model is based on subscription fees or service agreements for their AI products, including the Dual-Expert Model™ for automating pharmacy workflows. Clients typically enter contracts specifying terms of service and the scope of automation, enabling pharmacies to leverage AI agents for operational improvements. Pricing plans reflect the complexity and scale of the pharmacy's needs, with costs associated with deploying AI bots and ongoing support. Transaction volumes include the number of tasks automated daily, further contributing to financial arrangements with pharmacy clients.TJM Labs plans to launch new AI-driven automation products targeting pharmacy operations, with specific release dates yet to be announced. The company aims to expand its market presence by entering new geographic regions, particularly targeting additional markets in Canada by the end of 2025. The recent Series A funding of USD 15.00 mn will support these initiatives, enabling the development of new products and the expansion into these targeted markets.

## Funding rounds

- Series B, Jul 2, 2026, $75M — Updata Partners, Arthur Ventures, Elephant

## Investors

- Updata Partners (https://capitalatlas.ai/funds/updata-partners) — Series B
- Arthur Ventures (https://capitalatlas.ai/funds/arthur-ventures) — Series B
- Elephant (https://capitalatlas.ai/funds/elephant) — Series B